FDA adds heavy metals contamination to its list of concerns about kratom

Warning letter on tainted kratom illustrates complicated regulatory picture for botanical

27-Nov-2018

By Hank Schultz

The kratom market has suffered another black eye with the release of a warning letter from FDA citing a marketer for material that was contaminated with salmonella. The letter also illustrates the ongoing regulatory ferment surrounding the botanical.

FDA issues warning letters on tianeptine 'supplements' making opioid-related claims

21-Nov-2018

By Stephen Daniells

The US Food and Drug Administration (FDA) sent warning letters to two companies selling products marketed as ‘dietary supplements’ and labeled as containing tianeptine, which is being illegally claimed to treat opioid use disorder (OUD), pain, and anxiety.

FDA's Gottlieb issues public statement about continued illegal opioid treatment claims for kratom

13-Sep-2018

By Hank Schultz

Commissioner Scott Gottlieb, MD, of US Food and Drug Administration, has issued a public statement about the continued marketing of kratom as an opioid withdrawal medication and announced more warning letters sent to marketers of the botanical.

FDA adds heavy metals contamination to its list of concerns about kratom

The US Food and Drug Administration has warned consumers against kratom products because of heavy metal contamination. The announcement joins numerous warnings the agency has issued in recent years on the botanical.

Related Topics

Warning letter on tainted kratom illustrates complicated regulatory picture for botanical

FDA issues warning letters on tianeptine 'supplements' making opioid-related claims

FDA's Gottlieb issues public statement about continued illegal opioid treatment claims for kratom